These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38184239)

  • 1. Safety-Net Primary Care and Endocrinology Clinicians' Knowledge and Perspectives on Screening for Nonalcoholic Fatty Liver Disease: A Mixed-Methods Evaluation.
    Fantasia KL; Austad K; Mohanty A; Long MT; Walkey A; Drainoni ML
    Endocr Pract; 2024 Mar; 30(3):270-277. PubMed ID: 38184239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care.
    Gracen L; Hayward KL; Aikebuse M; Williams S; Russell A; O'Beirne J; Powell EE; Valery PC
    Diabet Med; 2022 Jun; 39(6):e14799. PubMed ID: 35100462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD).
    Cusi K; Isaacs S; Barb D; Basu R; Caprio S; Garvey WT; Kashyap S; Mechanick JI; Mouzaki M; Nadolsky K; Rinella ME; Vos MB; Younossi Z
    Endocr Pract; 2022 May; 28(5):528-562. PubMed ID: 35569886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis.
    Patel PJ; Banh X; Horsfall LU; Hayward KL; Hossain F; Johnson T; Stuart KA; Brown NN; Saad N; Clouston A; Irvine KM; Russell AW; Valery PC; Williams S; Powell EE
    Intern Med J; 2018 Feb; 48(2):144-151. PubMed ID: 29083080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to Identify Advanced Nonalcoholic Fatty Liver Disease in the Primary Care Setting.
    Golabi P; Shah D; Younossi ZM
    Semin Liver Dis; 2023 May; 43(2):142-148. PubMed ID: 37414024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease.
    Wieland AC; Quallick M; Truesdale A; Mettler P; Bambha KM
    Dig Dis Sci; 2013 Oct; 58(10):2809-16. PubMed ID: 23843097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.
    Newton KP; Hou J; Crimmins NA; Lavine JE; Barlow SE; Xanthakos SA; Africa J; Behling C; Donithan M; Clark JM; Schwimmer JB;
    JAMA Pediatr; 2016 Oct; 170(10):e161971. PubMed ID: 27478956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes.
    Kuchay MS; Choudhary NS; Mishra SK; Misra A
    Diabetes Metab Syndr; 2020; 14(6):2233-2239. PubMed ID: 33336648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.
    Lazarus JV; Ekstedt M; Marchesini G; Mullen J; Novak K; Pericàs JM; Roel E; Romero-Gómez M; Ratziu V; Tacke F; Cortez-Pinto H; Anstee QM;
    J Hepatol; 2020 Jan; 72(1):14-24. PubMed ID: 31518646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and Referral Practices for Nonalcoholic Fatty Liver Disease by Race and Ethnicity in a Primary Care Clinic.
    Patil R; Nagaraj PK; Kuo HC; Noel G
    J Racial Ethn Health Disparities; 2023 Jun; 10(3):1392-1397. PubMed ID: 35556223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting.
    Vieira Barbosa J; Lai M
    Hepatol Commun; 2021 Feb; 5(2):158-167. PubMed ID: 33553966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening Patterns of Nonalcoholic Fatty Liver Disease in Children with Obesity in Canadian Primary Care: A Cross-Sectional Study.
    Morkem R; Theal R; Barber D; Flemming J; Queenan J; Kehar M
    Can J Gastroenterol Hepatol; 2022; 2022():8435581. PubMed ID: 36594051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary care practitioners survey of non-alcoholic fatty liver disease.
    Said A; Gagovic V; Malecki K; Givens ML; Nieto FJ
    Ann Hepatol; 2013; 12(5):758-65. PubMed ID: 24018493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on nonalcoholic fatty liver disease.
    Provencher DM
    JAAPA; 2014 Jul; 27(7):18-22. PubMed ID: 24901731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional study.
    Shaheen AA; Riazi K; Medellin A; Bhayana D; Kaplan GG; Jiang J; Park R; Schaufert W; Burak KW; Sargious M; Swain MG
    CMAJ Open; 2020; 8(2):E370-E376. PubMed ID: 32414883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005-2016.
    Ciardullo S; Sala I; Perseghin G
    Diabetes Res Clin Pract; 2020 Sep; 167():108358. PubMed ID: 32745698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study.
    Hallsworth K; Dombrowski SU; McPherson S; Anstee QM; Avery L
    Transl Behav Med; 2020 Oct; 10(4):1016-1030. PubMed ID: 31120519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening patterns and identification of non-alcoholic fatty liver disease in obese children in canadian primary care.
    Theal R; Morkem R; Queenan J; Barber D
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36944043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease in Endocrinology Clinics.
    Younossi ZM; Henry L; Isaacs S; Cusi K
    Endocr Pract; 2023 Nov; 29(11):912-918. PubMed ID: 37406857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.